Interferon beta (IFNβ) was the first disease-modifying therapy available to treat multiple sclerosis (MS), providing patients with a treatment that resulted in reduced relapse rates and delays in …

Mar 6, 2024 · A man-made version of them can treat multiple sclerosis (MS), especially interferon betas. Learn about when doctors use them, how well they work, their risks, and side effects.

Jun 2, 2023 · In this viewpoint, we summarize the evidence on IFN-β mechanisms of action in MS with a focus on its antiviral properties, especially against EBV. We synopsize the role of IFNs …

Interferon beta-1a is in a class of medications called immunomodulators. It works by decreasing inflammation and preventing nerve damage that may cause symptoms of multiple sclerosis.

Interferon therapies hold a significant position in the treatment landscape for multiple sclerosis (MS). Their development arose from the need to manage this complex autoimmune disorder …

Oct 1, 2007 · Multiple sclerosis (MS) is the leading nontraumatic cause of neurologic disability in young adults. Interferon-β, approved for use in 1993, was the first treatment to modify the …

Since 1981, clinical and real-world observational studies have demonstrated the effectiveness of interferon therapies in reducing relapse rate, disability worsening/progression, and the number …

Nov 1, 2025 · These drugs are man-made versions. They can reduce (and might prevent) the inflammation that damages nerves in MS. You inject beta interferons at home. When you start …

Jan 25, 2021 · Beta interferons (IFN-β) are pleiotropic cytokines with antiviral properties. They play important roles in the pathogenesis of multiple sclerosis (MS), an incurable immune …

Interferon beta-1a (Rebif) is a medication administered by subcutaneous (SC) injection, three times a week for two weeks, then three times a week for two weeks, then three times a week …